REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 106 filers reported holding REPLIMUNE GROUP INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $462,003 | -37.2% | 26,161 | -3.3% | 0.02% | -46.4% |
| Q4 2022 | $736,114 | +1.0% | 27,063 | -35.9% | 0.03% | +16.7% |
| Q3 2022 | $729,000 | -10.8% | 42,209 | -9.7% | 0.02% | 0.0% |
| Q2 2022 | $817,000 | +6.8% | 46,733 | +3.7% | 0.02% | +20.0% |
| Q1 2022 | $765,000 | -24.9% | 45,079 | +20.0% | 0.02% | -23.1% |
| Q4 2021 | $1,018,000 | -22.1% | 37,564 | -14.7% | 0.03% | -33.3% |
| Q3 2021 | $1,306,000 | -28.0% | 44,047 | -6.7% | 0.04% | -29.1% |
| Q2 2021 | $1,813,000 | +57.4% | 47,193 | +25.0% | 0.06% | +41.0% |
| Q1 2021 | $1,152,000 | -20.4% | 37,762 | -0.5% | 0.04% | -33.9% |
| Q4 2020 | $1,447,000 | +4.2% | 37,933 | -37.1% | 0.06% | -14.5% |
| Q3 2020 | $1,389,000 | -13.3% | 60,352 | -6.4% | 0.07% | -17.9% |
| Q2 2020 | $1,603,000 | – | 64,500 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 4,763,380 | $129,088,000 | 18.25% |
| Atlas Venture Life Science Advisors, LLC | 3,209,627 | $86,981,000 | 7.99% |
| Redmile Group, LLC | 3,866,512 | $104,782,000 | 2.38% |
| FRAZIER MANAGEMENT LLC | 650,862 | $17,638,000 | 1.36% |
| Mesirow Financial Investment Management, Inc. | 15,326 | $415,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,075,464 | $29,145,000 | 1.03% |
| EMERALD ADVISERS, LLC | 989,958 | $26,828,000 | 0.99% |
| BVF INC/IL | 926,529 | $25,109,000 | 0.91% |
| Integral Health Asset Management, LLC | 100,000 | $2,710,000 | 0.75% |
| Artal Group S.A. | 900,000 | $24,390,000 | 0.66% |